JPMorgan, Bank of America, Citigroup and Wells Fargo are all expected to post higher revenue year-on-year in Q3. Read more ...

While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two ...

Eric Fine discusses the current economic landscape, focusing on the implications of stagflation, geopolitical risks, and ...

The stock market's only certainty is its cyclical nature: long-term overperformance eventually leads to underperformance, and ...

Q2 sales +50% as iDose TR & Epioxa drive 85% gross margin; 2026 guide raised. Read here for a detailed investment analysis.

The yield on the 10-year note finished October 9, 2026 at 5.24%, while the 2-year note ended at 4.80%. The chart below ...

The Roundhill Memory ETF offers diversified exposure to the memory chip sector and key beneficiaries of the AI-driven memory ...

Palantir (PLTR) is executing an aggressive upward-guidance cycle, with FY26 revenue growth now projected at 82% YoY, up from ...

Micron is rated a Strong Buy with a 5.88x forward P/E as a valuation anomaly amid multi-year supply deficits and imminent ...

As of September 2026, the latest Q-ratio is at 2.11. As of September 2026, the Q-Ratio is 148% above its historic average.

Humana surged after its main Medicare Advantage contract regained a 4-star CMS rating for 2027, a major profit catalyst. Read ...

The Vanguard S&P 500 Growth ETF offers S&P 500 growth exposure but lags QQQ long-term. Click for a detailed look at VOOG.